Third-quarter results are due before markets open Nov. 12; Aveanna's call follows at 10 a.m. Eastern.

Aveanna Healthcare (AVAH) will release Q3 results on Nov. 12, 2026, before market open, followed by a conference call at 10 a.m. ET. The call and webcast can be accessed live or replayed later. Aveanna provides healthcare services across 39 states, focusing on pediatric and adult care.

Original reporting
Published Oct 22, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AVAH
Neutral
high confidence
Mentioned
$AVAH
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AVAHNeutralMed
01

Why it matters

The earnings release date announcement is a routine but material catalyst that can drive short‑term price movement.

02

Market read

Investors will watch the Nov 12 earnings for guidance on revenue growth and margins, influencing sector sentiment.

03

What to watch

Potential regulatory changes or payer contract updates that could be discussed during the call.

Relevance 5/10Novelty 5/10Timing: pre‑market on Nov 12, 2026

Background

Aveanna Healthcare provides pediatric and adult home health services across the US and is scheduled to release its Q3 results.

Company-level read

Ticker impact

$AVAHNeutralHigh confidence
Context

Aveanna Healthcare announced the date and time for its Q3 earnings release and conference call.

Expected impact

likely heightened volatility with potential upside or downside depending on the earnings surprise.

Evidence & confidence

Earnings date announcements are standard catalysts; the market will react once results are posted.

Market effects

May affect the broader healthcare services sector as peers are compared to Aveanna's upcoming results.

US healthcare market focus; limited regional spillover.

Low global impact beyond sector peers.

Counterpoint

If the market has already priced in strong earnings, the announcement could trigger a sell‑off on disappointment.

Key entities

  • Aveanna Healthcare Holdings Inc.

    Provider of pediatric and adult healthcare services, ticker AVAH.

Related articles

$AVAHHighAI 8/10

Aveanna Healthcare Earnings Call Signals Broader Growth, Higher Guidance

Aveanna Healthcare (AVAH) reported Q3 revenue of $695.5M, up 11.8%, and adjusted EBITDA of $100.1M, up 25%. All segments grew, with Home Health and Hospice up 15.6%, Private Duty Services up 11.6%, and Medical Solutions up 9.1%. The company raised 2026 guidance to revenue above $2.695B and adjusted EBITDA above $374M, citing growth in preferred payers and state rate enhancements. Management highlighted caregiver shortages and California rate uncertainty as risks.

$AVAHMedAI 8/10

What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call

Aveanna Healthcare (AVAH) reported Q3 revenue growth of 15.6% to $72.1M in Home Health and Hospice, and 9.1% to $49.2M in Medical Solutions. CEO Shaner cautioned that 20-25% growth is unsustainable. The company secured $30M in California funding for rate increases, aiming for permanency. Aveanna reconfirmed long-term growth targets and plans to focus acquisitions on Home Health and Hospice. It reported $492M in liquidity and $1.52B in variable-rate debt, all hedged through 2029.

$AVAHHigh

Raymond James reiterates Strong Buy on Aveanna stock after beat

Raymond James reiterated a Strong Buy rating and $15.00 price target for Aveanna Healthcare (AVAH) after its Q3 2026 results beat estimates. AVAH reported adjusted EBITDA of $100.1M, 7.5% above consensus, and raised its 2026 EBITDA guidance to at least $374M. The stock trades at $13.09, with 13% upside to the target. RBC Capital increased its price target to $16.00, citing positive market positioning.